Jobs
-
The New York Microscopical Society has recognized Malvern Instruments Chief Technology Officer E. Neil Lewis with its Ernst Abbe Memorial Award for outstanding contributions to the science of microscopy. The society specifically cited Dr. Lewis’s… Read more . . .
-
The approximately 800 million inhalers sold annually worldwide generate approximately 10,000 tons of waste, estimates Graham Purkins of Novartis, a member of the the Device Working Group of IPAC-RS. In response to growing concern from… Read more . . .
-
Tokyo-based Eisai will co-promote three Novartis inhaled COPD therapies in Japan with Novartis Pharma K.K. Starting on December 1, 2011, both companies will promote Onbrez indacaterol inhalation capsules, with Novartis targeting flagship and university hospitals… Read more . . .
-
According to the Hong Kong Department of Health (DH), Nycomed (Hong Kong) has voluntarily recalled a batch of Omnaris ciclesonide nasal spray due “a quality defect.” The product, from batch number 137930, was manufactured in… Read more . . .
-
Two Phase 3 studies to evaluate the safety of twice daily doses of a fixed dose combination dry powder formulation of aclidinium bromide and formoterol fumarate in 3,500 patients with moderate to severe COPD have… Read more . . .
-
Ampio Pharmaceuticals has announced results of a randomized, double-blinded study of its intranasal Ampion, a biologic anti-inflammatory, for the treatment of nasal inflammation. According to the company, Ampion “is naturally produced by humans in response… Read more . . .
-
The upcoming Aerosols–Inhalation and Nasal Drug Products Workshop sponsored by the United States Pharmacopoeia’s General Chapters-Dosage Forms Expert Committee will take place at USP headquarters in Rockville, MD on December 12 and 13, and the… Read more . . .
-
Mylan gets Pfizer’s respiratory delivery platform, acquires global rights to generic Diskus products
US generics company Mylan Inc. has obtained worldwide rights to develop, manufacture and commercialize Pfizer’s generic equivalent to GlaxoSmithKline’s Advair Diskus and Seretide Diskus products for asthma and COPD using Pfizer’s proprietary dry powder inhalation technology.… Read more . . .
-
Within the last week, Discovery Laboratories has announced that its aerosolized KL4 surfactant has received orphan drug designation from the EU for the treatment of cystic fibrosis, and it has presented data on a new… Read more . . .
-
Sunovion is presenting results from a 26-week double-blind, randomized Phase 3 study of ciclesonide HFA nasal aerosol involving more than 1,100 patients with perennial allergic rhinitis (PAR) that showed statistically significant improvement in nasal symptoms… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland